{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:40:12Z","timestamp":1793194812020,"version":"4.5.0"},"reference-count":63,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Science and Technology Program","doi-asserted-by":"publisher","award":["2024NSFSC1745"],"award-info":[{"award-number":["2024NSFSC1745"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2622769","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:35:22Z","timestamp":1770366922000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Design, synthesis and biological evaluation of donepezil-safinamide hybrids as dual AChE and MAO-B inhibitor for Alzheimer\u2019s disease treatment"],"prefix":"10.1080","volume":"41","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[{"name":"School of Pharmacy, North Sichuan Medical College","place":["Nanchong, China"]},{"name":"Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, North Sichuan Medical College","place":["Nanchong, China"]},{"name":"Department of pharmacy, Meishan People\u2019s Hospital","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Sichuan Key Laboratory of Medical Imaging, North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongcheng","family":"Cao","sequence":"additional","affiliation":[{"name":"School of Pharmacy, North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"20","key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1016\/j.cell.2023.08.039","article-title":"Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology","volume":"186","author":"Mathys H","year":"2023","unstructured":"Mathys H, Peng Z, Boix CA, Victor MB, Leary N, Babu S, Abdelhady G, Jiang X, Ng AP, Ghafari K, et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology. Cell. 2023;186(20):4365\u20134385. e27.","journal-title":"Cell"},{"issue":"6699","key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"eadd6260","DOI":"10.1126\/science.add6260","article-title":"Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer\u2019s disease","volume":"384","author":"Princen K","year":"2024","unstructured":"Princen K, Van Dooren T, van Gorsel M, Louros N, Yang X, Dumbacher M, Bastiaens I, Coupet K, Dupont S, Cuveliers E, et al. Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer\u2019s disease. Science. 2024;384(6699):eadd6260.","journal-title":"Science"},{"issue":"12","key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1093\/brain\/awae292","article-title":"The emerging field of non-invasive brain stimulation in Alzheimer\u2019s disease","volume":"147","author":"Koch G","year":"2024","unstructured":"Koch G, Altomare D, Benussi A, Br\u00e9chet L, Casula EP, Dodich A, Pievani M, Santarnecchi E, Frisoni GB. The emerging field of non-invasive brain stimulation in Alzheimer\u2019s disease. Brain. 2024;147(12):4003\u20134016.","journal-title":"Brain"},{"issue":"21","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","article-title":"Alzheimer\u2019s disease: exploring the landscape of cognitive decline","volume":"15","author":"Tenchov R","year":"2024","unstructured":"Tenchov R, Sasso JM, Zhou QA. Alzheimer\u2019s disease: exploring the landscape of cognitive decline. ACS Chem Neurosci. 2024;15(21):3800\u20133827.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang J","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"116810","DOI":"10.1016\/j.ejmech.2024.116810","article-title":"Dual-target inhibitors based on acetylcholinesterase: novel agents for Alzheimer\u2019s disease","volume":"279","author":"Zhao X","year":"2024","unstructured":"Zhao X, Hu Q, Wang X, Li C, Chen X, Zhao D, Qiu Y, Xu H, Wang J, Ren L, et al. Dual-target inhibitors based on acetylcholinesterase: novel agents for Alzheimer\u2019s disease. Eur J Med Chem. 2024;279:116810.","journal-title":"Eur J Med Chem"},{"issue":"6","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41590-025-02152-4","article-title":"Cholinergic regulation of thymocyte negative selection","volume":"26","author":"Liu S","year":"2025","unstructured":"Liu S, Zheng C, Nechanitzky R, Luo P, Ramachandran P, Nguyen D, Elia AJ, Moghadas Jafari S, Law R, Snow BE, et al. Cholinergic regulation of thymocyte negative selection. Nat Immunol. 2025;26(6):881\u2013893.","journal-title":"Nat Immunol"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"108018","DOI":"10.1016\/j.nlm.2024.108018","article-title":"Cholinergic regulation of decision making under risk of punishment","volume":"217","author":"Kelly M","year":"2025","unstructured":"Kelly M, Garner M, Cooper EM, Orsini CA. Cholinergic regulation of decision making under risk of punishment. Neurobiol Learn Mem. 2025;217:108018.","journal-title":"Neurobiol Learn Mem"},{"issue":"1","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11030-024-10828-6","article-title":"Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies","volume":"29","author":"Kuzu B","year":"2025","unstructured":"Kuzu B, Alagoz MA, Demir Y, Gulcin I, Burmaoglu S, Algul O. Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies. Mol Divers. 2025;29(1):671\u2013693.","journal-title":"Mol Divers"},{"issue":"6","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1021\/acsomega.4c05527","article-title":"Newer therapeutic approaches in treating Alzheimer\u2019s disease: a comprehensive review","volume":"10","author":"Reddi Sree R","year":"2025","unstructured":"Reddi Sree R, Kalyan M, Anand N, Mani S, Gorantla VR, Sakharkar MK, Song B-J, Chidambaram SB. Newer therapeutic approaches in treating Alzheimer\u2019s disease: a comprehensive review. ACS Omega. 2025;10(6):5148\u20135171.","journal-title":"ACS Omega"},{"issue":"15","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1039\/D3CC06055A","article-title":"Detection of acetylcholinesterase and butyrylcholinesterase in vitro and in vivo using a new fluorescent probe","volume":"60","author":"Tang X","year":"2024","unstructured":"Tang X, Zhang Y, Wang Q, Li Z, Zhang C. Detection of acetylcholinesterase and butyrylcholinesterase in vitro and in vivo using a new fluorescent probe. Chem Commun (Camb). 2024;60(15):2082\u20132085.","journal-title":"Chem Commun (Camb)"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"117331","DOI":"10.1016\/j.ejmech.2025.117331","article-title":"Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors","volume":"287","author":"Dawood DH","year":"2025","unstructured":"Dawood DH, Anwar MM. Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors. Eur J Med Chem. 2025;287:117331.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00401-024-02712-2","article-title":"Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer\u2019s disease and related dementias","volume":"147","author":"Jaisa-Aad M","year":"2024","unstructured":"Jaisa-Aad M, Mu\u00f1oz-Castro C, Healey MA, Hyman BT, Serrano-Pozo A. Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer\u2019s disease and related dementias. Acta Neuropathol. 2024;147(1):66.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu P-P","year":"2019","unstructured":"Liu P-P, Xie Y, Meng X-Y, Kang J-S. History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther. 2019;4(1):29.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41423-020-0441-8","article-title":"Targeting monoamine oxidase to dampen NLRP3 inflammasome activation in inflammation","volume":"18","author":"S\u00e1nchez-Rodr\u00edguez R","year":"2021","unstructured":"S\u00e1nchez-Rodr\u00edguez R, Munari F, Angioni R, Venegas F, Agnellini A, Castro-Gil MP, Castegna A, Luisetto R, Viola A, Canton M. Targeting monoamine oxidase to dampen NLRP3 inflammasome activation in inflammation. Cell Mol Immunol. 2021;18(5):1311\u20131313.","journal-title":"Cell Mol Immunol"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"101957","DOI":"10.1016\/j.jchemneu.2021.101957","article-title":"The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders","volume":"114","author":"Jones DN","year":"2021","unstructured":"Jones DN, Raghanti MA. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J Chem Neuroanat. 2021;114:101957.","journal-title":"J Chem Neuroanat"},{"issue":"1","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3923\/ijp.2023.131.138","article-title":"Protective effect of fangchinoline against glaucoma and neuroinflammation in unilateral ocular hypertension in mice","volume":"19","author":"Li SL","year":"2023","unstructured":"Li SL, Ni NJ, Wu XM, Lan T, Yu YF. Protective effect of fangchinoline against glaucoma and neuroinflammation in unilateral ocular hypertension in mice. International J of Pharmacology. 2023;19(1):131\u2013138.","journal-title":"International J of Pharmacology"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3389\/fphar.2020.01197","article-title":"1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea Protects the Blood-Brain Barrier Against Ischemic Injury by Upregulating Tight Junction Protein Expression, Mitigating Apoptosis and Inflammation InVivo and In Vitro Model","volume":"11","author":"Yi X","year":"2020","unstructured":"Yi X, Xu C, Huang P, Zhang L, Qing T, Li J, Wang C, Zeng T, Lu J, Han Z. 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea Protects the Blood-Brain Barrier Against Ischemic Injury by Upregulating Tight Junction Protein Expression, Mitigating Apoptosis and Inflammation InVivo and In Vitro Model. Front Pharmacol. 2020;11:1197.","journal-title":"Front Pharmacol"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"111779","DOI":"10.1016\/j.biopha.2021.111779","article-title":"8-Formylophiopogonanone B antagonizes doxorubicin-induced cardiotoxicity by suppressing heme oxygenase-1-dependent myocardial inflammation and fibrosis","volume":"140","author":"Qin D","year":"2021","unstructured":"Qin D, Yue R, Deng P, Wang X, Zheng Z, Lv M, Zhang Y, Pu J, Xu J, Liang Y, et al. 8-Formylophiopogonanone B antagonizes doxorubicin-induced cardiotoxicity by suppressing heme oxygenase-1-dependent myocardial inflammation and fibrosis. Biomed Pharmacother. 2021;140:111779.","journal-title":"Biomed Pharmacother"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"111380","DOI":"10.1016\/j.intimp.2023.111380","article-title":"Severe inflammation in C57\/BL6 mice leads to prolonged cognitive impairment by initiating the IL-1\u03b2\/TRPM2 pathway","volume":"128","author":"Yang Y","year":"2024","unstructured":"Yang Y, Yao Z, Wang H, Jia S, Wang M, Wang S, Yun D. Severe inflammation in C57\/BL6 mice leads to prolonged cognitive impairment by initiating the IL-1\u03b2\/TRPM2 pathway. Int Immunopharmacol. 2024;128:111380.","journal-title":"Int Immunopharmacol"},{"issue":"25","key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1021\/acsomega.5c00134","article-title":"New prospects in the inhibition of monoamine oxidase-B (MAO-B) utilizing propargylamine derivatives for the treatment of Alzheimer\u2019s disease: a review","volume":"10","author":"Chatzipieris FP","year":"2025","unstructured":"Chatzipieris FP, Kokkalis A, Georgiou N, Petsas E, Apostolou EV, Vougioukalakis GC, Mavromoustakos T. New prospects in the inhibition of monoamine oxidase-B (MAO-B) utilizing propargylamine derivatives for the treatment of Alzheimer\u2019s disease: a review. ACS Omega. 2025;10(25):26208\u201326232.","journal-title":"ACS Omega"},{"issue":"29","key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.2174\/0929867328666210203204710","article-title":"Monoamine oxidase-B (MAO-B) inhibitors in the treatment of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"28","author":"Zeynep z","year":"2021","unstructured":"Zeynep z, Mehmet Abdullah A, Mer Faruk B, Ecio l, Selim G. Monoamine oxidase-B (MAO-B) inhibitors in the treatment of Alzheimer\u2019s and Parkinson\u2019s disease. Curr. Med. Chem. 2021;28(29):6045\u20136065.","journal-title":"Curr. Med. Chem"},{"issue":"7","key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/JCMA.0000000000001252","article-title":"A 2025 update on treatment strategies for the Alzheimer\u2019s disease spectrum","volume":"88","author":"Wu C-K","year":"2025","unstructured":"Wu C-K, Fuh J-L. A 2025 update on treatment strategies for the Alzheimer\u2019s disease spectrum. J Chin Med Assoc. 2025;88(7):495\u2013502.","journal-title":"J Chin Med Assoc"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117277"},{"issue":"1","key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"2270781","DOI":"10.1080\/14756366.2023.2270781","article-title":"Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer\u2019s disease","volume":"38","author":"Zou D","year":"2023","unstructured":"Zou D, Liu R, Lv Y, Guo J, Zhang C, Xie Y. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer\u2019s disease. J Enzyme Inhib Med Chem. 2023;38(1):2270781.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"8","key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/pharmaceutics17080958","article-title":"Recent advances in donepezil delivery systems via the nose-to-brain pathway","volume":"17","author":"Jon J","year":"2025","unstructured":"Jon J, Jeong J, Jung J, Cho H, Song K, Kim E-S, Lee SH, Han E, Chung W-H, Moon A, et al. Recent advances in donepezil delivery systems via the nose-to-brain pathway. Pharmaceutics. 2025;17(8):958.","journal-title":"Pharmaceutics"},{"issue":"22","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung J","year":"2012","unstructured":"Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J, Franklin MC, Height JJ. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem. 2012;55(22):10282\u201310286.","journal-title":"J Med Chem"},{"issue":"7","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00415-025-13230-w","article-title":"Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson\u2019s disease","volume":"272","author":"Khalid MB","year":"2025","unstructured":"Khalid MB, Shahzad F, Siddiqui MR, Abedin MZU, Hulou S, Shami B, Ahmed SI. Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson\u2019s disease. J Neurol. 2025;272(7):486.","journal-title":"J Neurol"},{"issue":"23","key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors:\u2009safinamide and coumarin analogs","volume":"50","author":"Binda C","year":"2007","unstructured":"Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors:\u2009safinamide and coumarin analogs. J Med Chem. 2007;50(23):5848\u20135852.","journal-title":"J Med Chem"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.09.031"},{"issue":"5","key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.bmc.2014.12.057","article-title":"Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer\u2019s disease","volume":"23","author":"Meena P","year":"2015","unstructured":"Meena P, Nemaysh V, Khatri M, Manral A, Luthra PM, Tiwari M. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer\u2019s disease. Bioorg Med Chem. 2015;23(5):1135\u20131148.","journal-title":"Bioorg Med Chem"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejmech.2017.02.043","article-title":"Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer\u2019s disease","volume":"130","author":"Dias KST","year":"2017","unstructured":"Dias KST, de Paula CT, dos Santos T, Souza INO, Boni MS, Guimar\u00e3es MJR, da Silva FMR, Castro NG, Neves GA, Veloso CC, et al. Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2017;130:440\u2013457.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2014.09.081","article-title":"Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer\u2019s disease","volume":"87","author":"Huang L","year":"2014","unstructured":"Huang L, Miao H, Sun Y, Meng F, Li X. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer\u2019s disease. Eur J Med Chem. 2014;87:429\u2013439.","journal-title":"Eur J Med Chem"},{"issue":"7","key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bmc.2015.01.045","article-title":"Isoindoline-1,3-dione derivatives targeting cholinesterases: design, synthesis and biological evaluation of potential anti-Alzheimer\u2019s agents","volume":"23","author":"Guzior N","year":"2015","unstructured":"Guzior N, Bajda M, Rakoczy J, Brus B, Gobec S, Malawska B. Isoindoline-1,3-dione derivatives targeting cholinesterases: design, synthesis and biological evaluation of potential anti-Alzheimer\u2019s agents. Bioorg Med Chem. 2015;23(7):1629\u20131637.","journal-title":"Bioorg Med Chem"},{"issue":"22","key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.bmcl.2017.09.055","article-title":"Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer\u2019s disease","volume":"27","author":"Sang Z","year":"2017","unstructured":"Sang Z, Wang K, Wang H, Yu L, Wang H, Ma Q, Ye M, Han X, Liu W. Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett. 2017;27(22):5053\u20135059.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"e2200084","DOI":"10.1002\/ardp.202200084","article-title":"Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase\u2010B inhibitors","volume":"355","author":"Sudevan ST","year":"2022","unstructured":"Sudevan ST, Rangarajan TM, Al\u2010Sehemi AG, Nair AS, Koyiparambath VP, Mathew B. Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase\u2010B inhibitors. Arch Pharm (Weinheim). 2022;355(8):e2200084.","journal-title":"Arch Pharm (Weinheim)"},{"issue":"22","key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1016\/j.bmc.2016.09.050","article-title":"Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson\u2019s disease","volume":"24","author":"Wang Z","year":"2016","unstructured":"Wang Z, Wu J, Yang X, Cai P, Liu Q, Wang KDG, Kong L, Wang X. Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson\u2019s disease. Bioorg Med Chem. 2016;24(22):5929\u20135940.","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"e202200629","DOI":"10.1002\/cmdc.202200629","article-title":"2\u2010Hydroxy\u20104\u2010benzyloxylimine resveratrol derivatives as potential multifunctional agents for the treatment of Parkinson\u2019s disease","volume":"18","author":"Cao Z","year":"2023","unstructured":"Cao Z, Zhang T, Fu X, Wang X, Xia Q, Zhong L, Zhu J. 2\u2010Hydroxy\u20104\u2010benzyloxylimine resveratrol derivatives as potential multifunctional agents for the treatment of Parkinson\u2019s disease. ChemMedChem. 2023;18(6):e202200629.","journal-title":"ChemMedChem"},{"issue":"23","key":"e_1_3_3_40_1","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1021\/acs.jmedchem.0c01663","article-title":"Computational fragment-based design facilitates discovery of potent and selective monoamine oxidase-B (MAO-B) inhibitor","volume":"63","author":"Jin C-F","year":"2020","unstructured":"Jin C-F, Wang Z-Z, Chen K-Z, Xu T-F, Hao G-F. Computational fragment-based design facilitates discovery of potent and selective monoamine oxidase-B (MAO-B) inhibitor. J Med Chem. 2020;63(23):15021\u201315036.","journal-title":"J Med Chem"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","first-page":"116074","DOI":"10.1016\/j.bmc.2021.116074","article-title":"Novel 3-benzylidene\/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"35","author":"Cao Z","year":"2021","unstructured":"Cao Z, Song Q, Yu G, Liu Z, Cong S, Tan Z, Deng Y. Novel 3-benzylidene\/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem. 2021;35:116074.","journal-title":"Bioorg Med Chem"},{"issue":"38","key":"e_1_3_3_42_1","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1016\/S0040-4039(03)01775-1","article-title":"The first synthesis of the epoxide-containing macrolactone nucleus of oximidine I","volume":"44","author":"Harvey JE","year":"2003","unstructured":"Harvey JE, Raw SA, Taylor RJK. The first synthesis of the epoxide-containing macrolactone nucleus of oximidine I. Tetrahedron Lett. 2003;44(38):7209\u20137212.","journal-title":"Tetrahedron Lett"},{"issue":"3","key":"e_1_3_3_43_1","first-page":"307","article-title":"Total synthesis of three new dihydrostilbenes from Bulbophllum odoratissimum","volume":"17","author":"Lin JG","year":"2006","unstructured":"Lin JG, Zhang WG, Zhao R, Niu ZY, Bao K, Liu DL, Wang NL, Yao XS. Total synthesis of three new dihydrostilbenes from Bulbophllum odoratissimum. Chin. Chem. Lett. 2006;17(3):307\u2013309.","journal-title":"Chin. Chem. Lett"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","first-page":"117613","DOI":"10.1016\/j.ejmech.2025.117613","article-title":"Design, synthesis and biological evaluation of N-substituted nipecotamide derivatives as multifunctional agents for epilepsy treatment","volume":"292","author":"Li W","year":"2025","unstructured":"Li W, Hong L, Li L, Yuan Y, Ding Y, Zhu J, Wang C, Cao Z, Tian X. Design, synthesis and biological evaluation of N-substituted nipecotamide derivatives as multifunctional agents for epilepsy treatment. Eur J Med Chem. 2025;292:117613.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","first-page":"130680","DOI":"10.1016\/j.molstruc.2021.130680","article-title":"Structure-supercooling property relationship of phenylethyl phenylacetate derivatives and analogue","volume":"1241","author":"Liu S","year":"2021","unstructured":"Liu S, Yin D, Li W, Liu D, Zhou X. Structure-supercooling property relationship of phenylethyl phenylacetate derivatives and analogue. J. Mol. Struct. 2021;1241:130680.","journal-title":"J. Mol. Struct"},{"issue":"11","key":"e_1_3_3_46_1","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1021\/acs.oprd.9b00376","article-title":"Mutagenic impurities in 1-hydroxybenzotriazole (HOBt)","volume":"23","author":"Treitler DS","year":"2019","unstructured":"Treitler DS, Marriott AS, Chadwick J, Quirk E. Mutagenic impurities in 1-hydroxybenzotriazole (HOBt). Org Process Res Dev. 2019;23(11):2562\u20132566.","journal-title":"Org Process Res Dev"},{"key":"e_1_3_3_47_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2012.08.003","article-title":"Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors","volume":"45","author":"Legoabe LJ","year":"2012","unstructured":"Legoabe LJ, Petzer A, Petzer JP. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors. Bioorg Chem. 2012;45:1\u201311.","journal-title":"Bioorg Chem"},{"key":"e_1_3_3_48_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejmech.2013.01.039","article-title":"A novel series of tacrine\u2013selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer\u2019s disease","volume":"62","author":"Lu C","year":"2013","unstructured":"Lu C, Zhou Q, Yan J, Du Z, Huang L, Li X. A novel series of tacrine\u2013selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2013;62:745\u2013753.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phymed.2017.12.032","article-title":"Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants","volume":"40","author":"Larit F","year":"2018","unstructured":"Larit F, Elokely KM, Chaurasiya ND, Benyahia S, Nael MA, Le\u00f3n F, Abu-Darwish MS, Efferth T, Wang Y-H, Belouahem-Abed D, et al. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants. Phytomedicine. 2018;40:27\u201336.","journal-title":"Phytomedicine"},{"issue":"10","key":"e_1_3_3_50_1","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/acs.jnatprod.6b00440","article-title":"Isolation of acacetin from Calea urticifolia with inhibitory properties against human monoamine oxidase-A and -B","volume":"79","author":"Chaurasiya ND","year":"2016","unstructured":"Chaurasiya ND, Gogineni V, Elokely KM, Le\u00f3n F, N\u00fa\u00f1ez MJ, Klein ML, Walker LA, Cutler SJ, Tekwani BL. Isolation of acacetin from Calea urticifolia with inhibitory properties against human monoamine oxidase-A and -B. J Nat Prod. 2016;79(10):2538\u20132544.","journal-title":"J Nat Prod"},{"issue":"10","key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/biom12101470","article-title":"Discovery of MAO-B inhibitor with machine learning, topomer CoMFA, molecular docking and multi-spectroscopy approaches","volume":"12","author":"Zheng L","year":"2022","unstructured":"Zheng L, Qin X, Wang J, Zhang M, An Q, Xu J, Qu X, Cao X, Niu B. Discovery of MAO-B inhibitor with machine learning, topomer CoMFA, molecular docking and multi-spectroscopy approaches. Biomolecules. 2022;12(10):1470.","journal-title":"Biomolecules"},{"issue":"7","key":"e_1_3_3_52_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/1062936X.2025.2537248","article-title":"Targeting MAO-B selectivity: computational screening, docking, and molecular dynamics insights","volume":"36","author":"Thai KM","year":"2025","unstructured":"Thai KM, Pham DT, Ngo TM, Nguyen HT, Nguyen PV, Pham TQ, Nguyen DN, Nguyen QT, Le MT. Targeting MAO-B selectivity: computational screening, docking, and molecular dynamics insights. SAR QSAR Environ Res. 2025;36(7):583\u2013619.","journal-title":"SAR QSAR Environ Res"},{"key":"e_1_3_3_53_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2016.07.043","article-title":"Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE\/BuChE and 15-LOX","volume":"123","author":"Pourabdi L","year":"2016","unstructured":"Pourabdi L, Khoobi M, Nadri H, Moradi A, Moghadam FH, Emami S, Mojtahedi MM, Haririan I, Forootanfar H, Ameri A, et al. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE\/BuChE and 15-LOX. Eur J Med Chem. 2016;123:298\u2013308.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_3_54_1","doi-asserted-by":"crossref","first-page":"13953","DOI":"10.1038\/s41598-021-93458-4","article-title":"Acetylcholinesterase and monoamine oxidase-B inhibitory activities by ellagic acid derivatives isolated from Castanopsis cuspidata var. sieboldii","volume":"11","author":"Oh JM","year":"2021","unstructured":"Oh JM, Jang H-J, Kang M-G, Song S, Kim D-Y, Kim JH, Noh J-I, Park JE, Park D, Yee S-T, et al. Acetylcholinesterase and monoamine oxidase-B inhibitory activities by ellagic acid derivatives isolated from Castanopsis cuspidata var. sieboldii. Sci Rep. 2021;11(1):13953.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_3_55_1","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1080\/14756366.2020.1784892","article-title":"Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors","volume":"35","author":"Sa\u011fl\u0131k BN","year":"2020","unstructured":"Sa\u011fl\u0131k BN, Osmaniye D, Acar \u00c7evik U, Levent S, Kaya \u00c7avu\u015fo\u011flu B, Atl\u0131 Eklio\u011flu \u00d6, \u00d6zkay Y, Koparal AS, Kaplanc\u0131kl\u0131 ZA. Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors. J Enzyme Inhib Med Chem. 2020;35(1):1422\u20131432.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"e_1_3_3_56_1","doi-asserted-by":"crossref","first-page":"e2100450","DOI":"10.1002\/ardp.202100450","article-title":"Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE\/MAO-B dual inhibitors","volume":"355","author":"Osmaniye D","year":"2022","unstructured":"Osmaniye D, Evren AE, Sa\u011fl\u0131k BN, Levent S, \u00d6zkay Y, Kaplanc\u0131kl\u0131 ZA. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE\/MAO-B dual inhibitors. Arch Pharm (Weinheim). 2022;355(3):e2100450.","journal-title":"Arch Pharm (Weinheim)"},{"issue":"1","key":"e_1_3_3_57_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong J","year":"2018","unstructured":"Dong J, Wang N-N, Yao Z-J, Zhang L, Cheng Y, Ouyang D, Lu A-P, Cao D-S. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform. 2018;10(1):29.","journal-title":"J Cheminform"},{"issue":"1","key":"e_1_3_3_58_1","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina A","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.","journal-title":"Sci Rep"},{"issue":"3","key":"e_1_3_3_59_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di L","year":"2003","unstructured":"Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. High throughput artificial membrane permeability assay for blood\u2013brain barrier. Eur J Med Chem. 2003;38(3):223\u2013232.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_60_1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.05.045","article-title":"Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment","volume":"335","author":"Xiang H","year":"2021","unstructured":"Xiang H, Zhang Q, Han Y, Yang L, Zhang Y, Liu Q, Zhang Z, Zhang L. Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment. J Control Release. 2021;335:498\u2013514.","journal-title":"J Control Release"},{"issue":"1","key":"e_1_3_3_61_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s10020-025-01255-w","article-title":"Inhibition of diacylglycerol O-acyltransferase 1 provides neuroprotection by inhibiting ferroptosis in ischemic stroke","volume":"31","author":"Zeng Y","year":"2025","unstructured":"Zeng Y, Guo R, Chen S, Lin Y, Cao S, Wang X, Zhang S, Xu H, Qing W, Yang H, et al. Inhibition of diacylglycerol O-acyltransferase 1 provides neuroprotection by inhibiting ferroptosis in ischemic stroke. Mol Med. 2025;31(1):191.","journal-title":"Mol Med"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02792"},{"key":"e_1_3_3_63_1","first-page":"32","article-title":"Design, synthesis, biological evaluation and docking studies of 2-hydroxy-4-benzyloxy chalcone derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"33","author":"Li W","year":"2025","unstructured":"Li W, Huang J, Chen Z, Zhang D, He L, Guo Y, Zhong L, Yang C, Yang C, Zeng M, et al. Design, synthesis, biological evaluation and docking studies of 2-hydroxy-4-benzyloxy chalcone derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. Curr Med Chem. 2025;33:32.","journal-title":"Curr Med Chem"},{"issue":"10","key":"e_1_3_3_64_1","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1080\/15548627.2023.2213984","article-title":"Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment","volume":"19","author":"Li Q","year":"2023","unstructured":"Li Q, Zhao Y, Guo H, Li Q, Yan C, Li Y, He S, Wang N, Wang Q. Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment. Autophagy. 2023;19(10):2639\u20132656.","journal-title":"Autophagy"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2622769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:35:29Z","timestamp":1770366929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2622769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2622769"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2622769","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2622769"}}